Lotta Molander is a Global Product Manager covering GE Healthcare’s continuous chromatography portfolio.
In this interview, she shares her insights on how GE sees the opportunities of continuous processing applications in biologics.
We have had the pleasure to collaborate with Gerard Gach, Chief Marketing Officer at LEWA-Nikkiso Bioprocess Group since our launch meeting in 2017.
With over 28 years in filtration/separation industry, he shares his insights on how continuous production is evolving.
We caught up with the Global Technology Partners from NNE – Morten Munk, Jeffery Odum and Niels Guldager – for their exclusive insights on various market appetites to CM and views on barriers to technology uptake.
‘Our experience shows that several companies worldwide are technology-ready, and that they have demonstrated robustness of continuous bioprocessing. The decision to advance will come down to hard quality and economic data,’
Enjoy the following presentations:
Validation for Continuous Manufacturing & Inspection Readiness
Continuous Chromatography Simplified for GMP Environments
End-to-end Continuous: Is this possible?